Keyphrases
DYRK2
100%
Protease Inhibitors
98%
Pyrano
66%
5-dicarbonitriles
66%
Anti-glioma
66%
Catalytic Synthesis
66%
Syrbactin
66%
Immunoproteasome Inhibitor
66%
Constitutive Proteasome
66%
2-pyridone
66%
Cancer Progression
66%
Chlorophenyl
66%
Heat Shock Factor 1 (HSF1)
66%
Anticancer Bioactivity
66%
Bone Degeneration
66%
Pyrazole
66%
AKT2
66%
Myeloma
66%
Dual Inhibition
66%
One-pot Two-step Reaction
66%
Amino
66%
Anticancer Activity
61%
3D Neurospheres
50%
Patient-derived
50%
Clinically Significant
44%
Glioblastoma Cells
44%
Malignancy
42%
Glioblastoma Cell Lines
38%
Glioma Stem Cells
33%
Neurosphere Formation
33%
PSMB5
33%
Synergistic Cytotoxicity
33%
Pseudomonas Syringae
33%
Triple-negative Breast Cancer Cells
33%
Virulence Factors
33%
Non-cancer
33%
In Vivo Activity
33%
Cell Death
33%
Multiple Myeloma
33%
Bortezomib
33%
Inhibitory Activity
33%
Non-small Cell Lung Cancer (NSCLC)
33%
Mouse Xenograft Model
33%
Cancer Cell Lines
33%
Myeloma Cells
33%
High Mortality Rate
33%
Global Problems
33%
Resistant mutants
33%
Drug Resistance
33%
Cancer Cells
33%
Guanidine Carbonate
22%
Breast
22%
Anticancer Properties
22%
Enhanced Cytotoxicity
22%
Lung Primary
22%
Bioactive
22%
Small Molecule Kinase Inhibitors
22%
Lung Cancer
22%
Liver
22%
Small Molecule Inhibitors
22%
Natural Products
22%
Betaine
22%
HSF1 Inhibitors
19%
Transcription Factor
19%
Glioma Cell Lines
16%
Glioma Cells
16%
Cytotoxicity
16%
Glioblastoma
16%
EC50
16%
Inhibitory Properties
16%
Glioma Malignancy
16%
Glioma
16%
Novel Therapeutics
16%
Growth Inhibition
16%
Oncogenic Pathways
16%
Patient Survival
16%
AKT Pathway
16%
Glioma Growth
16%
Co-target
9%
Oncogenic Kinases
9%
Orthotopic Xenograft Model
9%
KRIBB11
9%
Survival Mechanism
9%
Triple-negative Breast Cancer
9%
26S Proteasome
9%
Proteostasis
9%
Breast Cancer Burden
9%
Proteotoxic Stress
9%
Druggable Targets
9%
Resistant Cells
9%
Apoptosis
9%
Inhibitor Resistant
9%
Biochemistry, Genetics and Molecular Biology
Proteasome Inhibitor
74%
Proteasome
74%
Intravenous Immunoglobulin
66%
HSF1
66%
Kinase
25%
Phosphotransferase
25%
Transcription Factors
14%
Mortality Rate
11%
Low Drug Dose
11%
Virulence Factor
11%
Pseudomonas syringae
11%
Drug Resistance
11%
Enzyme
11%
Cell Death
11%
Cytotoxicity
11%
Protein Homeostasis
7%
Infancy
7%